We are live on ! Find out more
RA

Ramius Advisors Portfolio holdings

AUM $95.2M
1-Year Est. Return 7.33%
This Fund
S&P 500
This Quarter Est. Return
+32.12%
1 Year Est. Return
+7.33%
3 Year Est. Return
+186.73%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$233M
AUM Growth
-$193M
Cap. Flow
-$211M
Cap. Flow %
-90.87%
Top 10 Hldgs %
82.3%
Holding
91
New
44
Increased
8
Reduced
9
Closed
29

Top Buys

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$28M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$10.1M
3
TECD
Tech Data Corp
TECD
+$9.56M
4
CY
Cypress Semiconductor
CY
+$9.47M
5
BOLD
Audentes Therapeutics, Inc
BOLD
+$8.29M

Top Sells

Rank Stock Value
1
MLNX
Mellanox Technologies, Ltd.
MLNX
+$70.6M
2
CELG
Celgene Corp
CELG
+$68.9M
3
GHDX
Genomic Health, Inc.
GHDX
+$29.2M
4
ACIA
Acacia Communications Inc
ACIA
+$23.6M
5
AGN
Allergan plc
AGN
+$21.4M

Sector Composition

Rank Sector Weight
1 Healthcare 37.54%
2 Technology 17.91%
3 Consumer Discretionary 4.3%
4 Communication Services 3.04%
5 Financials 1.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
76
PUT
Teva Pharmaceuticals
TEVA
$36.3B
– –
-330,100
Closed -$62K
VTRS icon
77
PUT
Viatris
VTRS
$20.1B
– –
-110,000
Closed -$103K
AVYA
78
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
– –
-160,851
Closed -$1.65M
S
79
CALL
DELISTED
Sprint Corporation
S
– –
-475,700
Closed -$156K
PVTL
80
CALL
DELISTED
Pivotal Software, Inc.
PVTL
– –
-1,125,000
Closed -$44K
CRZO
81
DELISTED
Carrizo Oil & Gas Inc
CRZO
– –
-131,001
Closed -$1.13M
PSDO
82
DELISTED
Presidio, Inc. Common Stock
PSDO
– –
-25,623
Closed -$433K
ONCE
83
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-188,336
Closed -$18.3M
STI
84
DELISTED
SunTrust Banks, Inc.
STI
– –
-276,668
Closed -$19M
MCRN
85
DELISTED
Milacron Holdings Corp.
MCRN
– –
-604,473
Closed -$10.1M
GHDX
86
DELISTED
Genomic Health, Inc.
GHDX
– –
-430,490
Closed -$29.2M
UBNK
87
DELISTED
United Financial Bancorp, Inc.
UBNK
– –
-72,218
Closed -$984K
VSM
88
PUT
DELISTED
Versum Materials, Inc.
VSM
– –
-85,000
Closed -$5K
BID
89
PUT
DELISTED
Sotheby's
BID
– –
-50,200
Closed -$3K
CELG
90
DELISTED
Celgene Corp
CELG
– –
-693,905
Closed -$68.9M
CELG
91
PUT
DELISTED
Celgene Corp
CELG
– –
-337,500
Closed -$47K
1 2 3
4

Similar funds

ACM
Acrisure Capital Management Austin, Texas $98.8M AUM
CWM
Catalyst Wealth Management Atlanta, Georgia $107M AUM
HLCM
Hickory Lane Capital Management New York $81.7M AUM 4.68% 1-Year Est. Return
ETM
Euclidean Technologies Management Seattle, Washington $109M AUM 7.18% 1-Year Est. Return
CFA
Compass Financial Advisors Fort Wayne, Indiana $78.9M AUM 0.9% 1-Year Est. Return
ACM
Ascendant Capital Management Los Angeles, California $75.7M AUM 12.68% 1-Year Est. Return
UPC
Utah Peaks Capital Park City, Utah $75.4M AUM
AMC
Asset Management Corp Northbrook, Illinois $128M AUM 6.72% 1-Year Est. Return

Ramius Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Ramius Advisors held 91 positions worth $233M, down 45% from $426M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Ramius Advisors withdrew a net $211M in Q4 2019, closing 29 positions and reducing 9 holdings. Its most notable exit was Celgene Corp, an estimated $68.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 38% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Ramius Advisors opened a new position in Medicines Co worth $35.7M.

  • Ramius Advisors's largest Q4 2019 buy was Medicines Co: 419,826 shares worth $35.7M.
  • Ramius Advisors added most to Wellcare Health Plans, Inc. in Q4 2019, an estimated $10.1M increase.
  • Ramius Advisors's biggest Q4 2019 reduction was Mellanox Technologies, Ltd., cutting an estimated $70.6M.
  • Ramius Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $68.9M.
  • Ramius Advisors's ten largest holdings make up 82% of its $233M portfolio in Q4 2019.
  • Ramius Advisors opened 44 new positions and closed 29 in Q4 2019.
  • Ramius Advisors's portfolio value fell 45% quarter-over-quarter to $233M.

Based on Ramius Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.